interest
case
anorect
signet
ring
carcinoma
first
present
earli
stage
diseas
show
aggress
diseas
undetect
behavior
type
histolog
mislead
diagnosi
braincn
metastasi
colorect
cancer
crc
rare
occur
case
leptomening
carcinomatosi
lmc
extrem
rare
crc
symptom
sign
lmc
pleomorph
may
local
three
compart
cerebr
hemispher
cranial
nerv
spinal
cord
root
treatment
metastat
rectal
cancer
improv
last
year
lot
chang
toward
longer
surviv
improv
qualiti
life
chang
diseas
chronic
condit
howev
case
overal
surviv
onset
lmc
week
revis
evid
treatment
signet
ring
histolog
rectal
cancer
specif
treatment
recommend
histolog
aggress
behavior
could
consid
separ
entiti
classic
adenocarcinoma
histolog
data
case
male
signific
past
medic
histori
feb
present
increas
constip
later
associ
rectal
bleed
april
gener
bone
pain
involv
chest
wall
dorsal
spine
pelvi
pr
examin
show
mass
almost
occlud
lumen
locat
cm
anal
verg
lab
baselin
blood
count
result
follow
white
blood
cell
neutrophil
hemoglobin
hb
gdl
mcv
fl
mch
pg
platelet
renal
liver
function
test
within
normal
rang
baselin
carcinoembryon
antigen
ngdl
proctocolonoscopi
show
mass
cm
anal
canal
extend
proxim
cm
biopsi
histopatholog
examin
result
confirm
poorli
differenti
adenocarcinoma
focal
signet
ring
morpholog
arrang
sheet
cord
minim
acinar
format
imag
pelvic
mri
show
rectal
mass
circumferenti
thicken
strand
extend
pelvic
side
wall
figur
multipl
larg
left
iliac
mesorect
lymph
node
reach
size
cm
multipl
foci
hyperintens
enhanc
detect
involv
lumbar
sacral
spine
iliac
bone
proxim
femura
computer
tomographi
chest
abdomen
pelvi
show
rectal
mass
cm
left
iliac
lymph
node
cm
right
upper
lung
nodul
cm
liver
metastas
bone
scan
confirm
widespread
activ
osseou
lesion
involv
spine
rib
pelvic
bone
figur
spectct
suggest
diffus
bone
infiltr
figur
june
receiv
palli
radiotherapi
pelvi
dose
gray
fraction
improv
rectal
bleed
schedul
start
palli
chemotherapi
patient
becam
pale
develop
progress
prolong
drop
hemoglobin
platelet
level
figur
receiv
multipl
unit
pack
red
blood
cell
transfus
improv
hematolog
paramet
bone
marrow
biopsi
confirm
diagnosi
malign
bone
marrow
infiltr
signet
ring
cell
posit
neg
markedli
reduc
hematopoiet
cell
patient
height
cm
weight
kg
surfac
area
juli
start
zoledron
acid
mg
iv
capecitabin
mg
oral
twice
daili
day
xelox
protocol
condit
fit
receiv
folforinox
requir
occasion
pack
rbc
platelet
transfus
first
day
capecitabin
gradual
start
show
clinic
improv
pain
rectal
bleed
well
hematolog
paramet
due
time
cycl
two
hb
gdl
platelet
wbc
neutrophil
oxaliplatin
half
usual
dose
ie
mg
instead
mg
ad
capecitabin
zoledron
acid
also
given
antiegfr
therapi
ad
ra
test
yet
report
bevacizumab
consid
due
thrombocytopenia
increas
risk
bleed
due
time
next
cycl
hb
gdl
platelet
wbc
neutrophil
time
oral
mucos
grade
dysphagia
support
treatment
given
treatment
hold
hb
gdl
platelet
wbc
neutrophil
show
improv
mucos
dysphagia
third
cycl
given
exactli
second
one
ie
dose
reduct
oxaliplatin
addit
capecitabin
zoledron
acid
present
emerg
depart
complain
diplopia
nasal
regurgit
vital
stabl
left
diverg
squint
ct
brain
show
promin
bilater
hypodens
collect
left
linear
opac
diffus
cortic
effac
figur
mri
brain
show
diffus
mening
thicken
enhanc
evid
sphenoid
ethmoid
mucos
thicken
figur
carcinoembryon
antigen
tripl
ngml
radiat
oncologist
encourag
start
rt
fear
infecti
process
csf
tap
empir
antimicrobi
start
includ
antivir
acyclovir
mg
iv
q
hour
day
oseltamivir
mg
oral
twice
daili
day
antibiot
ceftriaxon
mg
everi
hour
day
levofloxacin
mg
intraven
everi
hour
day
vancomycin
mg
intraven
everi
hour
day
microbiolog
test
neg
includ
aerob
anaerob
blood
cultur
sputum
acid
fast
bacilli
mer
coronaviru
screen
aspergillu
galactomannan
antigen
serum
blastomyc
antibodi
ab
brucella
abortu
melitensi
test
cocci
cf
id
coxiella
burnetii
cryptococc
antigen
ag
serum
histoplasma
ab
syphili
tp
patient
show
sign
improv
later
highresolut
ct
chest
show
two
right
lung
nodul
largest
cm
diamet
ct
abdomen
pelvi
show
progress
rectal
lesion
newli
develop
innumer
small
hypodens
liver
lesion
cm
diamet
patient
ran
grave
cours
expir
worldwid
year
colorect
cancer
crc
third
common
cancer
male
second
femal
fourth
caus
cancer
death
male
third
femal
arab
countri
crc
first
common
cancer
male
second
femal
second
caus
cancer
mortal
male
femal
histolog
classifi
colorect
carcinoma
adenocarcinoma
ac
medullari
carcinoma
mucin
ac
signet
ring
cell
carcinoma
srcc
subtyp
mucin
ac
mac
lesion
extracellular
mucin
srcc
tumor
signet
ring
cell
promin
intracytoplasm
mucin
almost
srcc
origin
stomach
rest
colon
rectum
pancrea
urinari
bladder
breast
srcc
constitut
colorect
cancer
colorect
srcc
present
advanc
stage
posit
ln
distant
metastas
poor
surviv
prognost
unfavor
independ
stage
compar
ac
colorect
srcc
tend
occur
younger
age
affect
right
side
poorli
differenti
recur
poor
surviv
express
mucinrel
gene
show
disrupt
ecadherin
betacatenin
complex
amplif
low
kra
high
braf
mutat
high
msi
loss
protein
express
ecadherin
may
contribut
highgrad
invas
natur
colorect
srcc
current
case
patient
young
year
analrect
lesion
local
advanc
associ
distant
metastas
ran
rapid
grave
cours
skelet
metastas
skm
crc
may
reach
radiotherapi
system
therapi
use
therapi
use
isol
skm
rare
occur
crc
usual
associ
liver
lung
metastas
skm
younger
patient
rectum
caecum
primarili
srcc
crc
skm
affect
vertebr
column
hippelvi
long
bone
bone
skm
usual
present
bone
pain
patholog
fractur
time
crc
diagnosi
onset
skm
rang
day
median
month
skelet
scintigraphi
detect
skm
high
sensit
palin
xray
help
symptomat
lesion
assess
fractur
risk
question
scintigraph
find
ct
help
imag
techniqu
unclear
wholebodi
mri
petct
sensit
specif
method
detect
skm
hybrid
techniqu
like
spectct
petct
petmri
combin
strength
differ
compon
avoid
weak
tradit
treatment
skm
includ
radiat
surgeri
chemotherapi
denosumab
zoledron
acid
reduc
pain
skelet
morbid
patient
skm
year
patient
isol
skm
aliv
compar
metastas
coexist
median
surviv
month
current
case
skm
initi
site
metastasi
develop
month
follow
initi
diagnosi
present
bone
pain
tender
confirm
bone
scintigraphi
spectct
receiv
palli
rt
zoledron
acid
system
chemotherapi
mild
improv
overal
surviv
onset
skm
month
bone
marrow
metastasi
bmm
notic
necropsi
crc
patient
chemotherapi
rare
use
extrem
rare
absenc
liver
lung
metastas
increas
liver
lung
metastas
common
metastat
site
associ
bmm
solid
tumor
bone
case
follow
liver
brain
lung
metastas
earli
featur
bmm
includ
microangiopath
hemolyt
anemia
leukoerythroblastosi
case
clinic
patient
present
anemia
thrombocytopenia
neutropenia
bicytopenia
encount
pancytopenia
case
hematolog
find
suspect
base
imag
use
modern
techniqu
malign
cell
found
bm
patient
stage
iiii
time
cur
surgeri
howev
clinic
relev
micrometastasi
bm
valid
mostli
valu
may
limit
unless
support
clinic
find
leukoerythroblast
reaction
abnorm
peripher
blood
count
despit
bm
biopsi
surest
fastest
method
diagnosi
mri
fdg
pet
petct
sensit
detect
bmm
bmm
crc
primarili
treat
chemotherapi
without
target
therapi
agent
commonli
use
fluoropyrimidin
oxaliplatin
occasion
bevacizumab
lead
clinic
improv
mani
patient
cytopenia
secondari
bmm
increas
risk
infect
bleed
also
hinder
deliveri
effect
chemotherapi
bmm
usual
carri
poor
prognosi
median
surviv
month
perform
statu
metastat
site
platelet
count
import
prognost
surviv
patient
thrombocytopenia
shorter
normal
platelet
count
month
vs
month
braincn
metastasi
crc
rare
occur
case
leptomening
carcinomatosi
lmc
extrem
rare
crc
rare
sole
site
intracrani
diseas
symptom
sign
lmc
pleomorph
may
local
three
compart
cerebr
hemispher
cranial
nerv
spinal
cord
root
headach
diplopia
backneck
pain
common
csf
cytolog
gold
standard
lmc
diagnosi
although
csf
cytolog
sensit
specif
low
neg
predict
valu
ct
scan
abnorm
case
lmc
howev
contrastenhanc
mri
higher
sensit
specif
without
treatment
median
surviv
patient
lmc
week
patient
usual
die
progress
leptomening
system
cancer
bulki
leptomening
diseas
concurr
cn
diseas
epidur
cord
compress
poor
perform
statu
poor
prognost
factor
intrathec
system
chemotherapi
may
use
limit
efficaci
current
case
lmc
suspect
clinic
base
neurolog
find
diplopia
squint
mri
howev
concomit
mucos
thicken
paranas
sinu
rais
issu
secondari
mening
howev
lack
respons
multitud
antimicrobi
go
lmc
overal
surviv
onset
lmc
week
case
report
work
hospit
direct
financi
indirect
financi
career
person
belief
conflict
